RedHill Biopharma

@RedHillBio Receives Notice of Allowance for New U.S. Patent Covering its Combination Therapy for Oncology: http://ir.redhillbio.com  #RDHL

@RedHillBio to Present at Cantor Fitzgerald Global Healthcare Conference on Sep 26, 2017: live webcast on http://ir.redhillbio.com  #RDHL

@RedHillBio Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.: http://ir.redhillbio.com  #RDHL

@RedHillBio to Present at BioPharm America International Partnering Conference on Sep 26, 2017: http://ir.redhillbio.com  #RDHL #BioPharmUSA

@RedHillBio to Present at Rodman & Renshaw Conference on Sep 12, 2017: listen to live webcast on http://ir.redhillbio.com  #RDHL

@RedHillBio Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium: http://ir.redhillbio.com  #RDHL

@RedHillBio Provides 2017 Semi-Annual Business Update: http://ir.redhillbio.com/ 

@RedHillBio Unanimous Positive DSMB Recommendation for Continuation of RHB-104 PIII Study for Crohn’s: http://ir.redhillbio.com  #RDHL

@RedHillBio Reports 2017 Second Quarter Financial Results and hosts conference call today at 9am EST: http://ir.redhillbio.com  #RDHL

@RedHillBio to Host Second Quarter 2017 Financial Results Conference Call on July 25, 2017: http://ir.redhillbio.com  #RDHL

@RedHillBio Announces Last Patient Visit in BEKINDA Phase II Study for IBS-D: http://ir.redhillbio.com  #RDHL

@RedHillBio Announces Expected Timeline for DSMB and Updates on Enrollment in RHB-104 PIII for Crohn’s: http://ir.redhillbio.com  #RDHL

@RedHillBio to Host Conf Call on Successful Phase III Top-Line Results with BEKINDA for Acute Gastroenteritis: http://ir.redhillbio.com  #RDHL

@RedHillBio Announces Confirmatory Phase III Study Initiated with RHB-105 for H. pylori Infection: http://ir.redhillbio.com  #RDHL

@RedHillBio Announces Successful Phase III Top-Line Results with BEKINDA for Acute Gastroenteritis: http://ir.redhillbio.com  #RDHL

@RedHillBio Initiates Promotion of #Donnatal and #EnteraGam in the U.S.: http://ir.redhillbio.com  #RDHL

@RedHillBio to Present at 2017 BIO International Convention on June 20, 2017: listen to live webcast on http://ir.redhillbio.com  #RDHL

@RedHillBio Announces Poster Presentation of Positive RHB-105 PhIII Results for H. pylori Infection at #DDW17: http://ir.redhillbio.com  #RDHL

@RedHillBio Reports Q1/2017 Financial Results and hosts conference call today at 9am EDT: http://ir.redhillbio.com  #RDHL

@RedHillBio to Host First Quarter 2017 Financial Results Conference Call on May 3, 2017: http://ir.redhillbio.com  #RDHL